Shares of Johnson & Johnson (NYSE:JNJ) have been recently spotted trading -11.54% off of the 52-week high price. On the other end, company shares have been noted 8.48% away from the low price over the last 52-weeks. 52 week range of the stock remained $ 120.95 – 148.32. Switching over to some distances from popular moving averages, we see that the stock has been recorded -3.52% away from the 50 day moving average and -3.31% away from the 200 day moving average. Moving closer, we can see that shares have been trading 0.10% off of the 20-day moving average.
Johnson & Johnson (NYSE:JNJ) recently reported that Dominic J. Caruso, Executive Vice President, Chief Financial Officer, has selected to retire in September 2018 after a distinguished 19-year career with the Company. Caruso was elected CFO in 2007, and served as CFO longer than anyone in the company’s 132- year history.
Alex Gorsky, Chairman and Chief Executive Officer of Johnson & Johnson said “During his nearly 12 years as CFO, Dominic provided Credo-based leadership and financial stewardship through the economic downturn and was instrumental in helping the Company deliver significant gains over the past five years”. “Dominic made a big impact inside our company, and he is well-respected throughout our industry. We wish Dominic, his wife, Debbie, and their family the very best in the years ahead.”
Under Mr. Caruso’s leadership, the Company completed three of its largest acquisitions: Actelion, Synthes and Pfizer Consumer Health. He was also instrumental in driving growth and capital allocation strategies that led Johnson & Johnson to exceed our competitor composite, as well as most major indices, for total shareholder return in 2017 and over the last three-, five-, ten- and twenty-year periods. Throughout his career, he has placed an emphasis on teaching, coaching and developing future leaders. Mr. Caruso and his finance organization have established a best-in-class Talent Development program and have been stewards of sustainable financial principles.
The USA based company Johnson & Johnson (NYSE:JNJ) closed with change of 0.74% to $131.21 with the total traded volume of 6145504 shares versus to an average volume of 7.91M. The stock was down in the 5 days activity -2.34%. The one month performance of stock was low -1.46%. JNJ shares are below -7.90% for the quarter and driving a 2.45% rally over the course of the past year and is now down -6.09% since this point in 2018. Right now JNJ beta is 0.74. The average volatility for the week and month was at 2.20% and 1.87% respectively.